AMLODIPINE-OLMESARTAN 5-20 MG

Amlodipine and Olmesartan Medoxomil
$0.2347per EA

Strength

5; 20 mg/1; mg/1

NDC

31722044590

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209591

On Market Since

2/14/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price History

1W

0.0%

1M

-2.2%

3M

-4.9%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.7%